CATEGORIES: CMT Update

Amazing Opportunity: AntiGravity Exercise Study in New York City!

by | Jul 31, 2017 | 4 comments

Estela AlterG

HNF is excited to announce a new avenue of research for improving the physical and emotional well-being of individuals living with CMT. Beginning this summer and continuing through the coming year, we will be funding and conducting an exclusive research study for people with CMT featuring the AlterG anti-gravity treadmill in New York City!

CALL 212-600-4781 TO LEARN MORE AND TO ENROLL!

This incredible new technology allows patients to stand, walk, and be supported as needed to improve balance, gain endurance, and reach greater speed, all without the risk of falling! This innovative machine—which was designed by NASA—features an airtight casing and powerful series of fans. Patients are zipped in and are able to reduce their body weight and the effects of gravity down to 20%.

This new combination of “weightlessness” and support was enough to allow Estela Lugo, a patient with CMT, to run for the first time in her adult life. “I lost all movement from the knee down before the age of 10 and have been wearing AFO’s since kindergarten. I didn’t think I would ever experience running in my lifetime. I stepped into this machine and was running within a few minutes. There aren’t any words to completely describe how amazing that felt.” One year and 116 miles later, Estela is displaying encouraging results and is more determined than ever to bring this technology to the CMT community. “We believe that movement is medicine and can greatly improve quality of life. The AlterG gets patients moving in new ways and pushes the boundaries of disability.” We are hopeful that bringing the AlterG and more mobility activities to patients with CMT will help to improve independence and quality of life for the community. 

Dr. James Nussbaum, PT, PhD, SCS, EMT, physical therapist and research and clinical director of ProHealth & Fitness PT OT in Manhattan, is an expert in the rehabilitation of patients with CMT. He has been treating patients with CMT and other neuromuscular diseases for more than 15 years, and has presented his research throughout the US and abroad. Dr. Nussbaum is leading our AlterG exercise study in New York city, and the enrollment is currently open. Interested patients or family members should call 212.600.4781 and ask about the AlterG CMT study.

Study participants will have a diagnosis of CMT, and will come in for an extensive initial evaluation, and then will do 30 minute exercise sessions three times a week for three months. Patient will be re-evaluated at the conclusion of the study and then again three and nine months later to assess changes in balance, mobility, and quality of life.

Study participants will participate free of charge, and will agree to partake in the thrice weekly sessions and the assessments of the study. Patients of all abilities are eligible to be evaluated: those with and without braces, with and without assistive devices (canes, walkers, etc.) may be eligible.

TAKE THIS AMAZING OPPORTUNITY TO BENEFIT FROM THE CUTTING EDGE OF RESEARCH IN CMT, CALL TODAY! 212.600.4781 AND ASK ABOUT THE ALTERG CMT STUDY.

WWW.PROHEALTHPTOT.COM

Learn more on this topic

Related Blog Posts

Breaking News: First Therapeutic Gene Therapy to Treat an Inherited Neuropathy is Approved for Clinical Trial!

The first disease community to receive a therapeutic gene to the spinal cord for an ultra rare inherited neuropathy is Giant Axonal Neuropathy (GAN). Congratulations to Hannah’s Hope Fund (HHF), a 501(c)3 public charity, which has driven this collaborative research in less than six years. Six million dollars has been raised to date to fund pre-clinical and clinical research on this rare disease.

A Rare Disease Patient That Does It All!

A movie script could not play out like this. There are very few occasions when a rare disease patient becomes the topic of a story that is truly uplifting. Often the stories are tragic or disheartening. That was not the case, however, with CMT patient Kim Goodsell.

Hot Off the Press

One of the ways that some CMT patients first become aware of their disease is when they are given a drug treatment for another disease. This is termed chemotherapy-induced neurotoxicity. Drugs such as paclitaxel and the vinca alkaloids that are widely used in cancer treatment cause severe peripheral neuropathy and in some patients this exacerbates CMT, revealing it perhaps for the first time.

Kara Q&A: How to “support” a friend or family member that’s affected with Charcot-MarieTooth.

My name is Courtney Hollett, Fundraising Coordinator at the Hereditary Neuropathy Foundation. This time of year I count my blessing daily and wanted to share with you a Q&A session I had with a new supporter of HNF. Kara, like myself has many family members affected with CMT and I reached out to her to share her thoughts and advice about how to “support” a friend or family member that’s affected with Charcot-MarieTooth.

Collaboration is the Key to HNF Success

Collaboration is the Key to HNF Success

We at HNF are so proud of the accomplishments of those scientists we fund and are asking you to please continue to support our efforts. Our Therapeutic Research In Accelerated Discovery (TRIAD) program is a proven collaborative model in the drug discovery process.

Sneak Peak of Fall Newsletter: CMT Research Study Survey

My name is Elizabeth Francisco and I am a graduate student from the Genetic Counseling program at the University of North Carolina Greensboro. I am inviting you to participate in a research study. The goal of my study is to learn more about the experiences of people with Charcot-Marie-Tooth (CMT) with genetic counseling and genetic testing. Adults with CMT and parents or legal guardians of someone of any age who has a diagnosis of CMT are eligible to participate

Join the conversation

Leave a Comment

4 Comments

  1. Allison Moore

    Hi Collin, if the study shows benefits for patients with CMT, HNF will consider expanding a study globally contingent on funding. Thank you for your interest.

    Reply
  2. Collin Stoll

    I am in Portland Oregon and would very much like to participate if a branch study was set up here. I think Nike has an AlterG but not sure about OHSU.

    Reply
  3. Alllison Moore

    Hi Lesley, can you please share the name of the facility in Phoenix that has the AlterG. We will add them to our AlterG Directory and I would reach out to them. Have you done the AlterG? Do they specialize in CMT patient care? Allison Moore, HNF

    Reply
  4. Lesley Fry

    I wish I could participate. There is one 2 miles from my home near Phoenix.

    Reply

Leave a Reply to Collin Stoll Cancel reply

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news